Adamas Pharmaceuticals, Inc. - stock earnings

Stock symbol ADMS is outdated, potentially delisted? Maybe it is available on other exchange?

ADMS Quarterly earnings

Date	Earnings	Revenue
2021Q2	-12.3 million USD	22.0 million USD
2021Q1	-12.6 million USD	19.3 million USD
2020Q4	-18.3 million USD	21.0 million USD
2020Q3	-11.9 million USD	20.2 million USD

ADMS Yearly earnings

Date	Earnings	Revenue
2020	-57.4 million USD	74.5 million USD
2019	-105.2 million USD	54.6 million USD
2018	-131.0 million USD	34.0 million USD
2017	-89.5 million USD	571000 USD

ADMS

Price: $8.22

52 week price:

4.02

9.15

Earnings Per Share: -0.28 USD

P/E Ratio: -5.06

Exchange: NGM

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 1.3 million

Ebitda: -21.4 million

Market Capitalization: 371.0 million

Links:

ADMS on Yahoo Finance